SBRA Quote, Financials, Valuation and Earnings

Gladstone Commercial Corp. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 9.88%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat Gladstone Commercial Corp.'s return on equity of 5.96%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 10.41%. On the other hand Gladstone Commercial Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 8.79%. Given that Sabra Health Care REIT, Inc. has higher upside potential than Gladstone Commercial Corp., analysts believe Sabra Health Care REIT, Inc. is more attractive than Gladstone Commercial Corp..

Sabra Health Care REIT, Inc. has a beta of 0.674, which suggesting that the stock is 32.571% less volatile than S&P 500. In comparison Gladstone Commercial Corp. has a beta of 1.112, suggesting its more volatile than the S&P 500 by 11.181%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.31%. Gladstone Commercial Corp. offers a yield of 10.44% to investors and pays a quarterly dividend of $0.10 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. Gladstone Commercial Corp. pays out 453.52% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are larger than Gladstone Commercial Corp. quarterly revenues of $40.8M. Sabra Health Care REIT, Inc.'s net income of $22.5M is higher than Gladstone Commercial Corp.'s net income of $4M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.17x while Gladstone Commercial Corp.'s PE ratio is 62.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.12x versus 3.38x for Gladstone Commercial Corp.. Usually stocks with elevated PS ratios are considered overvalued.

National Health Investors, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 35.86%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat National Health Investors, Inc.'s return on equity of 10.31%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 10.41%. On the other hand National Health Investors, Inc. has an analysts' consensus of $85.63 which suggests that it could grow by 8.61%. Given that Sabra Health Care REIT, Inc. has higher upside potential than National Health Investors, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than National Health Investors, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.674, which suggesting that the stock is 32.571% less volatile than S&P 500. In comparison National Health Investors, Inc. has a beta of 0.667, suggesting its less volatile than the S&P 500 by 33.349%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.31%. National Health Investors, Inc. offers a yield of 4.62% to investors and pays a quarterly dividend of $0.92 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. National Health Investors, Inc. pays out 115.16% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are larger than National Health Investors, Inc. quarterly revenues of $90.6M. Sabra Health Care REIT, Inc.'s net income of $22.5M is lower than National Health Investors, Inc.'s net income of $32.5M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.17x while National Health Investors, Inc.'s PE ratio is 24.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.12x versus 10.21x for National Health Investors, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Omega Healthcare Investors, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 58.87%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat Omega Healthcare Investors, Inc.'s return on equity of 11.31%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 10.41%. On the other hand Omega Healthcare Investors, Inc. has an analysts' consensus of $47.13 which suggests that it could grow by 8.96%. Given that Sabra Health Care REIT, Inc. has higher upside potential than Omega Healthcare Investors, Inc., analysts believe Sabra Health Care REIT, Inc. is more attractive than Omega Healthcare Investors, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.674, which suggesting that the stock is 32.571% less volatile than S&P 500. In comparison Omega Healthcare Investors, Inc. has a beta of 0.568, suggesting its less volatile than the S&P 500 by 43.181%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.31%. Omega Healthcare Investors, Inc. offers a yield of 6.2% to investors and pays a quarterly dividend of $0.67 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. Omega Healthcare Investors, Inc. pays out 178.38% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are smaller than Omega Healthcare Investors, Inc. quarterly revenues of $314.2M. Sabra Health Care REIT, Inc.'s net income of $22.5M is lower than Omega Healthcare Investors, Inc.'s net income of $185M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.17x while Omega Healthcare Investors, Inc.'s PE ratio is 24.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.12x versus 11.14x for Omega Healthcare Investors, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Ventas, Inc. has a net margin of 11.18% compared to Sabra Health Care REIT, Inc.'s net margin of 4.61%. Sabra Health Care REIT, Inc.'s return on equity of 6.38% beat Ventas, Inc.'s return on equity of 2.14%.

Sabra Health Care REIT, Inc. has a consensus price target of $21.00, signalling upside risk potential of 10.41%. On the other hand Ventas, Inc. has an analysts' consensus of $85.65 which suggests that it could grow by 11.84%. Given that Ventas, Inc. has higher upside potential than Sabra Health Care REIT, Inc., analysts believe Ventas, Inc. is more attractive than Sabra Health Care REIT, Inc..

Sabra Health Care REIT, Inc. has a beta of 0.674, which suggesting that the stock is 32.571% less volatile than S&P 500. In comparison Ventas, Inc. has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.896%.

Sabra Health Care REIT, Inc. has a quarterly dividend of $0.30 per share corresponding to a yield of 6.31%. Ventas, Inc. offers a yield of 2.51% to investors and pays a quarterly dividend of $0.48 per share. Sabra Health Care REIT, Inc. pays 223.55% of its earnings as a dividend. Ventas, Inc. pays out 923.55% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Sabra Health Care REIT, Inc. quarterly revenues are $201.4M, which are smaller than Ventas, Inc. quarterly revenues of $1.5B. Sabra Health Care REIT, Inc.'s net income of $22.5M is lower than Ventas, Inc.'s net income of $68.7M. Notably, Sabra Health Care REIT, Inc.'s price-to-earnings ratio is 26.17x while Ventas, Inc.'s PE ratio is 144.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sabra Health Care REIT, Inc. is 6.12x versus 6.19x for Ventas, Inc.. Usually stocks with elevated PS ratios are considered overvalued.